The Ca2+-Activated K+ Channel of Intermediate Conductance:A Molecular Target for Novel Treatments?
Journal:
Current Drug Targets
Volume:
2
Page:
401-422
Author(s):
B. S. Jensen, D. Strobaek, S.-P. Olesen and P. Christophersen
Helicase Domain Containing Proteins in Human Disorders
Journal:
Current Genomics
Volume:
2
Page:
305-324
Author(s):
Adayabalam S. Balajee and Colette ApRhys
Oxytosis: A Novel Form of Programmed Cell Death
Journal:
Current Topics in Medicinal Chemistry
Volume:
1
Page:
497-506
Author(s):
Shirlee Tan, David Schubert and Pamela Maher
Oxidative Stress in Neurodegeneration: Mechanisms and Therapeutic Perspectives
Journal:
Current Topics in Medicinal Chemistry
Volume:
1
Page:
553-568
Author(s):
Antonio Contestabile
dUTPase in Human Neoplastic Cells as a Potential Target for Therapeutic Intervention
Journal:
Current Protein & Peptide Science
Volume:
2
Page:
349-360
Author(s):
Friedrich A. Grasser, Bernd F.M. Romeike, Gerald Niedobitek, John Nicholls and Elisabeth Kremmer
Thrombin Activable Fibrinolysis Inhibitor (TAFI): Molecular Genetics of an Emerging Potential Risk Factor for Thrombotic Disorders
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
1
Page:
59-74
Author(s):
M. B. Boffa, M. E. Nesheim and M. L. Koschinsky
Herpes Simplex Virus Vectors for the Nervous System
Journal:
Current Gene Therapy
Volume:
1
Page:
339-358
Author(s):
C. E. Lilley, R. H. Branston and R. S. Coffin
Fullerenes in Medicinal Chemistry and their Biological Applications
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
1
Page:
339-348
Author(s):
N. Tagmatarchis and H. Shinohara
FKBP Ligands as Novel Therapeutics for Neurological Disorders
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
1
Page:
377-397
Author(s):
C. Christner, T. Herdegen and G. Fischer
Immune Responses to Fungal Infections and Therapeutic Implications
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
1
Page:
189-197
Author(s):
M. Altamura, D. Casale, M. Pepe and A. Tafaro